93 related articles for article (PubMed ID: 15759988)
21. [Study on the inclusion compound of qucertin with hydroxypropyl-beta-cyclodextrin].
Shao W; Xie Q; Wang C; Mi G; Wang D
Zhong Yao Cai; 2002 Feb; 25(2):121-3. PubMed ID: 12599411
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
[TBL] [Abstract][Full Text] [Related]
23. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
24. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
Kopecký F; Kopecká B; Kaclík P
Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332
[TBL] [Abstract][Full Text] [Related]
25. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin.
Moyano JR; Arias-Blanco MJ; Gines JM; Rabasco AM; Pérez-Martínez JI; Mor M; Giordano F
J Pharm Sci; 1997 Jan; 86(1):72-5. PubMed ID: 9002462
[TBL] [Abstract][Full Text] [Related]
26. [Study of the inclusion compound of rutin with beta-cyclodextrin].
Shao W; Wang D; Mi G; Wang C
Zhong Yao Cai; 1998 Jan; 21(1):31-3. PubMed ID: 12567968
[TBL] [Abstract][Full Text] [Related]
27. Inclusion complexes of N-sulfamoyloxazolidinones with beta-cyclodextrin.
Kadri M; Djemil R; Abdaoui M; Winum JY; Coutrot F; Montero JL
Bioorg Med Chem Lett; 2005 Feb; 15(4):889-94. PubMed ID: 15686881
[TBL] [Abstract][Full Text] [Related]
28. Improvement of antifungal activity of 10-undecyn-1-ol by inclusion complexation with cyclodextrin derivatives.
Neoh TL; Tanimoto T; Ikefuji S; Yoshii H; Furuta T
J Agric Food Chem; 2008 May; 56(10):3699-705. PubMed ID: 18454543
[TBL] [Abstract][Full Text] [Related]
29. Insight into the structural deformations of beta-cyclodextrin caused by alcohol cosolvents and guest molecules.
Zhang H; Ge C; van der Spoel D; Feng W; Tan T
J Phys Chem B; 2012 Mar; 116(12):3880-9. PubMed ID: 22376204
[TBL] [Abstract][Full Text] [Related]
30. Novel behavior of O-methylated beta-cyclodextrins in inclusion of meso-tetraarylporphyrins.
Kano K; Nishiyabu R; Doi R
J Org Chem; 2005 Apr; 70(9):3667-73. PubMed ID: 15845005
[TBL] [Abstract][Full Text] [Related]
31. Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.
Dupuy N; Marquis S; Vanhove G; Bria M; Kister J; Vrielynck L
Appl Spectrosc; 2004 Jun; 58(6):711-8. PubMed ID: 15198824
[TBL] [Abstract][Full Text] [Related]
32. New cyclodextrin derivative 6-O-(2-hydroxybutyl)-beta-cyclodextrin: preparation and its application in molecular binding and recognition.
Sun HY; Bai Y; Zhao MG; Hao AY; Xu GY; Shen J; Li JY; Sun T; Zhang HC
Carbohydr Res; 2009 Oct; 344(15):1999-2004. PubMed ID: 19703683
[TBL] [Abstract][Full Text] [Related]
33. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
Garnero C; Longhi M
J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
[TBL] [Abstract][Full Text] [Related]
34. [Phenomena of supramolecular assembly fluid room temperature phosphorescence (II)--effects of alcohols on room temperature phosphorescence of cyclodextrin/4-iodo-4'-ethyl-biphenyl/bromocyclohexane system].
Zhu Y; Li L; Tong A
Guang Pu Xue Yu Guang Pu Fen Xi; 1998 Oct; 18(5):617-21. PubMed ID: 15825381
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
36. Studies of inclusion complexes of natural and modified cyclodextrin with (+)catechin by NMR and molecular modeling.
Jullian C; Miranda S; Zapata-Torres G; Mendizábal F; Olea-Azar C
Bioorg Med Chem; 2007 May; 15(9):3217-24. PubMed ID: 17350847
[TBL] [Abstract][Full Text] [Related]
37. Study on the supramolecular system of 5-(p-hydroxyphenyl)-10,15,20-tris-(4-chlorophenyl)porphyrin with cyclodextrins and its analytical characteristics.
Guo YJ; Zhang P; Chao JB; Shuang SM; Dong C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Dec; 71(3):946-50. PubMed ID: 18373951
[TBL] [Abstract][Full Text] [Related]
38. Effect of the acyl group and the dodecylsulfonate chain on the inclusion of pyrene inside the cavity of beta-cyclodextrin.
Rima J; Kyriacos S; Rida MA
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 74(1):10-5. PubMed ID: 19592293
[TBL] [Abstract][Full Text] [Related]
39. [Studies on the effects of steric hindrance of guest molecule on the formation of inclusion complexes by molecular luminescence].
Mu JZ; Huang GL; Zhang Y
Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Feb; 25(2):188-91. PubMed ID: 15852852
[TBL] [Abstract][Full Text] [Related]
40. Study on inclusion interaction of piroxicam with beta-cyclodextrin derivatives.
Xiliang G; Yu Y; Guoyan Z; Guomei Z; Jianbin C; Shaomin S
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Dec; 59(14):3379-86. PubMed ID: 14607235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
